Institutional investors purchased a net $1.3 million shares of PCYC during the quarter ended September 2013. This may signal that the smart money is gaining interest in this company as the 65.53% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FIDELITY MANAGEMENT & RESEARCH C... Bought 1.4 Million shares of Pharmacyclics Inc
T. ROWE PRICE ASSOCIATES, INC. Bought 1.0 Million shares of Pharmacyclics Inc
FRED ALGER MANAGEMENT, INC. Bought 432.3 Thousand shares of Pharmacyclics Inc